7-32495726-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015060.3(AVL9):c.17G>T(p.Arg6Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,261,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015060.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AVL9 | NM_015060.3 | c.17G>T | p.Arg6Ile | missense_variant | 1/16 | ENST00000318709.9 | NP_055875.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AVL9 | ENST00000318709.9 | c.17G>T | p.Arg6Ile | missense_variant | 1/16 | 2 | NM_015060.3 | ENSP00000315568.4 | ||
AVL9 | ENST00000409301.5 | c.17G>T | p.Arg6Ile | missense_variant | 1/15 | 5 | ENSP00000387011.1 | |||
AVL9 | ENST00000459629.1 | n.206G>T | non_coding_transcript_exon_variant | 1/2 | 2 | |||||
AVL9 | ENST00000485228.1 | n.301G>T | non_coding_transcript_exon_variant | 1/3 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000126 AC: 3AN: 23802Hom.: 0 AF XY: 0.000187 AC XY: 2AN XY: 10692
GnomAD4 exome AF: 0.0000892 AC: 99AN: 1109266Hom.: 0 Cov.: 31 AF XY: 0.0000969 AC XY: 51AN XY: 526546
GnomAD4 genome AF: 0.000190 AC: 29AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The c.17G>T (p.R6I) alteration is located in exon 1 (coding exon 1) of the AVL9 gene. This alteration results from a G to T substitution at nucleotide position 17, causing the arginine (R) at amino acid position 6 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at